These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34731088)

  • 1. Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma.
    Hu K; Xu Z; Yao L; Yan Y; Zhou L; Li J
    Aging (Albany NY); 2021 Nov; 13(21):24117-24135. PubMed ID: 34731088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment the value of Pyroptosis-Associated Gasdermin family genes in hepatocellular carcinoma: A Multi-Omics Comprehensive Analysis.
    Wei C; Zhou J; Tao W; Qin L; Zhang K; Huang J; Gao L; Zhou S
    J Cancer; 2024; 15(7):1966-1982. PubMed ID: 38434972
    [No Abstract]   [Full Text] [Related]  

  • 3. GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma.
    Yao L; Li J; Xu Z; Yan Y; Hu K
    Aging (Albany NY); 2022 Mar; 14(6):2758-2774. PubMed ID: 35321945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma.
    Peng LS; Duan SL; Li RQ; Wang D; Han YY; Huang T; Yu YP; Ou CL; Wang JP
    Front Oncol; 2022; 12():1043862. PubMed ID: 36505798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins.
    Mu M; Yu Q; Zhang Q; Guo J; Wang X; Sun X; Yu J
    Cancer Cell Int; 2022 Feb; 22(1):80. PubMed ID: 35164740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pyroptotic and Nonpyroptotic Roles of Gasdermins in Modulating Cancer Progression and Their Perspectives on Cancer Therapeutics.
    Hsu SK; Chen YE; Shu ED; Ko CC; Chang WT; Lin IL; Li CY; Gallego RP; Chiu CC
    Arch Immunol Ther Exp (Warsz); 2023 May; 71(1):14. PubMed ID: 37258998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pan-cancer analysis of the expression of gasdermin genes in tumors and their relationship with the immune microenvironment.
    Wang YY; Shi LY; Xu MH; Jing Y; Sun CC; Yang JH; Wang RN; Sheng NN; Zhang CF; Zhang L; Zhu ZT; Wang QJ
    Transl Cancer Res; 2021 Sep; 10(9):4125-4147. PubMed ID: 35116710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma.
    Huang H; Chen R; Deng X; Wang J; Chen J
    Oncol Lett; 2024 Feb; 27(2):85. PubMed ID: 38249806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
    Liu M; Zhao Z; Cai Y; Bi P; Liang Q; Yan Y; Xu Z
    Aging (Albany NY); 2021 Nov; 13(21):24205-24218. PubMed ID: 34747720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gasdermins: pore-forming activities and beyond.
    Zheng Z; Deng W; Lou X; Bai Y; Wang J; Zeng H; Gong S; Liu X
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):467-474. PubMed ID: 32294153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma.
    Liu X; He Y; Wang P; Hu J; Hao C; Wang Q; Yang Y; Sun Y; Ma B; Sun H; Xue D; Meng X
    Dis Markers; 2022; 2022():5791471. PubMed ID: 35280441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To die or not to die: Gasdermins in intestinal health and disease.
    Lin Z; Chen Q; Ruan HB
    Semin Immunol; 2024 Feb; 71():101865. PubMed ID: 38232665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 15. EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker.
    Chen R; Zhang Y
    J Cell Mol Med; 2020 Oct; 24(20):12107-12118. PubMed ID: 32935479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
    Lin T; Lin Z; Mai P; Zhang E; Peng L
    Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
    Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
    Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
    Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
    Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Expression and Copy Number Variation of Gasdermin (GSDM) Family Members, Pore-Forming Proteins in Pyroptosis, in Normal and Malignant Serous Ovarian Tissue.
    Berkel C; Cacan E
    Inflammation; 2021 Dec; 44(6):2203-2216. PubMed ID: 34091823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.